Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

5589 ARTÍCULOS , VIENDO DEL 2671 AL 2685

Advances in Parkinson's Disease Drugs

Di Stefano A, Marinelli L.

Biomolecules. 2021 Nov 5;11(11):1640. doi: 10.3390/biom11111640.

Mitochondria-Endoplasmic Reticulum Crosstalk in Parkinson's Disease: The Role of Brain Renin Angiotensin System Components

Sunanda T, Ray B, Mahalakshmi AM, Bhat A, Rashan L, Rungratanawanich W, Song BJ, Essa MM, Sakharkar MK, Chidambaram SB.

Biomolecules. 2021 Nov 10;11(11):1669. doi: 10.3390/biom11111669.

Inhibitors of Discoidin Domain Receptor (DDR) Kinases for Cancer and Inflammation

Denny WA, Flanagan JU.

Biomolecules. 2021 Nov 10;11(11):1671. doi: 10.3390/biom11111671.

Mapping the Diverse and Inclusive Future of Parkinson's Disease Genetics and Its Widespread Impact

Elsayed I, Martinez-Carrasco A, Cornejo-Olivas M, Bandres-Ciga S.

Genes (Basel). 2021 Oct 23;12(11):1681. doi: 10.3390/genes12111681.

Gene Therapeutic Approaches for the Treatment of Mitochondrial Dysfunction in Parkinson's Disease

Prasuhn J, Brüggemann N.

Genes (Basel). 2021 Nov 22;12(11):1840. doi: 10.3390/genes12111840.

NRF2 Activation and Downstream Effects: Focus on Parkinson's Disease and Brain Angiotensin

Parga JA, Rodriguez-Perez AI, Garcia-Garrote M, Rodriguez-Pallares J, Labandeira-Garcia JL.

Antioxidants (Basel). 2021 Oct 20;10(11):1649. doi: 10.3390/antiox10111649.

The Emerging Scenario of the Gut-Brain Axis: The Therapeutic Actions of the New Actor Kefir against Neurodegenerative Diseases

Pereira TMC, Côco LZ, Ton AMM, Meyrelles SS, Campos-Toimil M, Campagnaro BP, Vasquez EC.

Antioxidants (Basel). 2021 Nov 20;10(11):1845. doi: 10.3390/antiox10111845.

Dopamine in Health and Disease

Ekker M.

Biomedicines. 2021 Nov 9;9(11):1644. doi: 10.3390/biomedicines9111644.

Versatile Role of Prokineticins and Prokineticin Receptors in Neuroinflammation

Lattanzi R, Miele R.

Biomedicines. 2021 Nov 9;9(11):1648. doi: 10.3390/biomedicines9111648.

Ferroptosis as a Major Factor and Therapeutic Target for Neuroinflammation in Parkinson's Disease

Ko CJ, Gao SL, Lin TK, Chu PY, Lin HY.

Biomedicines. 2021 Nov 12;9(11):1679. doi: 10.3390/biomedicines9111679.

Metals in ALS TDP-43 Pathology

Koski L, Ronnevi C, Berntsson E, Wärmländer SKTS, Roos PM.

Int J Mol Sci. 2021 Nov 11;22(22):12193. doi: 10.3390/ijms222212193.

A Possible Role for HMG-CoA Reductase Inhibitors and Its Association with HMGCR Genetic Variation in Parkinson's Disease

Pierzchlińska A, Droździk M, Białecka M.

Int J Mol Sci. 2021 Nov 11;22(22):12198. doi: 10.3390/ijms222212198.

Protein Misfolding and Aggregation: The Relatedness between Parkinson's Disease and Hepatic Endoplasmic Reticulum Storage Disorders

Padilla-Godínez FJ, Ramos-Acevedo R, Martínez-Becerril HA, Bernal-Conde LD, Garrido-Figueroa JF, Hiriart M, Hernández-López A, Argüero-Sánchez R, Callea F, Guerra-Crespo M.

Int J Mol Sci. 2021 Nov 18;22(22):12467. doi: 10.3390/ijms222212467.

Targeting Mitochondria by Plant Secondary Metabolites: A Promising Strategy in Combating Parkinson's Disease

Fakhri S, Abdian S, Zarneshan SN, Akkol EK, Farzaei MH, Sobarzo-Sánchez E.

Int J Mol Sci. 2021 Nov 22;22(22):12570. doi: 10.3390/ijms222212570.

Exosomes in Ageing and Motor Neurone Disease: Biogenesis, Uptake Mechanisms, Modifications in Disease and Uses in the Development of Biomarkers and Therapeutics

Anakor E, Le Gall L, Dumonceaux J, Duddy WJ, Duguez S.

Cells. 2021 Oct 28;10(11):2930. doi: 10.3390/cells10112930.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias